The study was not set up to look at any differences between the two. It is an important point but we cant at the moment say anything about that, he said. He said the numbers were consistent with a relatively constant protection of about 70% at that stage. The Pfizer/BioNTech was available first so there is more data, but the Oxford/AstraZeneca was mostly used in the older age group. The numbers were very small and there was uncertainty over their significance, said the researchers.
The study was set up to look at differences between the two main groups.
( z0 set-up :ARG1 ( z1 study ) :ARG2 ( z2 look :ARG0 z1 :ARG1 ( z3 thing :ARG3-of ( z4 differ :ARG1 ( z5 group :quant 2 :mod ( z6 main ) ) ) ) ) )
(z0 / set-up-03
    :ARG1 (z1 / study-01)
    :ARG2 (z2 / look-01
              :ARG0 z1
              :ARG1 (z3 / thing
                        :ARG3-of (z4 / differ-02
                                     :ARG1 (z5 / group
                                               :quant 2
                                               :mod (z6 / main))))))
The study was set up to look at differences between the two main groups .
z0 :ARG1 z1
z0 :ARG2 z2
z2 :ARG0 z1
z2 :ARG1 z3
z3 :ARG3-of z4
z5 :mod z6
z5 :quant 0
z4 :ARG1 z5